| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.0051 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.0047 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |